James Halle

Optibrium has appointed James Halle as Chief Commercial Officer

Optibrium has announced the appointment of James Halle as Chief Commercial Officer.

James brings extensive software experience in the pharma industry and will guide the commercial success of the company.

With 20 years’ experience in business leadership, James will be responsible for driving global sales, marketing and customer success activities.

In his new role, he will manage Optibrium’s commercial team while working closely with senior leadership to develop and deliver the company’s product commercialisation strategy.

James joins Optibrium from Cytel, a clinical trials services and software business, where as the Global Head of Product Growth, he led the software division’s global commercial team, delivering innovative products to market and driving customer adoption.

His experience moving from individual software sales to enterprise solutions at Cytel will help drive the growth of Optibrium’s new cloud-based StarDrop, Cerella and Semeta discovery platforms.

Prior to Cytel, James held a range of leadership positions at IQVIA spending the final three years as Director of Global Technology Sales heading a large team across EMEA/APAC/LATAM and the US. James’ wealth of experience in software account management at companies including IBM and LexisNexis brings a fresh perspective to achieve Optibrium’s growth targets.

James reflected: “I am delighted to be joining Optibrium and to be part of such a talented team. The potential to increase the speed, efficiency and productivity of chemistry discovery programmes is vast.”